Vision Marine Technologies (VMAR) shares plunged 27% in recent Monday premarket activity after saying it signed securities purchase agreements with accredited and institutional investors to issue and sell units of its common shares for total gross proceeds of roughly $5.8 million.
Moderna (MRNA) shares dropped 19% after the company trimmed its 2025 revenue guidance to between $1.5 billion and $2.5 billion, down from its previous range of $2.5 billion to $3.5 billion.
Akoya Biosciences (AKYA) shares slipped 11% after Canaccord Genuity downgraded it to hold from buy with a $3.50 price target.
Cohu (COHU) stock was down almost 6% after Needham downgraded it to hold from buy.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.